APOL1 and kidney disorder: Furthermore, interferon signaling upregulation inpatients with LN may trigger nephropathy associated with apolipoprotein L1 (APOL1) risk-alleles (which are prevalent in individuals with Sub-Saharan African ancestry) by upregulating APOL1 mRNA expression and increasing genotype-associated disease severity [76].